Cargando…

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis

Several biomarkers from multiple sclerosis (MS) patients’ biological fluids have been considered to support diagnosis, predict disease course, and evaluate treatment response. In this study, we assessed the CSF concentration of selected molecules implicated in the MS pathological process. To investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucchini, Matteo, De Arcangelis, Valeria, Piro, Geny, Nociti, Viviana, Bianco, Assunta, De Fino, Chiara, Di Sante, Gabriele, Ria, Francesco, Calabresi, Paolo, Mirabella, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758105/ https://www.ncbi.nlm.nih.gov/pubmed/36215027 http://dx.doi.org/10.1007/s12035-022-03060-6

Ejemplares similares

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre
por: Lucchini, Matteo, et al.
Publicado: (2022)

Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach
por: Cicia, Alessandra, et al.
Publicado: (2022)

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients
por: Nociti, Viviana, et al.
Publicado: (2018)

The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
por: Biolato, Marco, et al.
Publicado: (2021)

Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
por: Bianco, Assunta, et al.
Publicado: (2021)

Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects
por: Nociti, Viviana, et al.
Publicado: (2022)

Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments
por: Seddone, Silvia, et al.
Publicado: (2021)

Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis
por: Lucchini, Matteo, et al.
Publicado: (2023)

Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis
por: Lucchini, Matteo, et al.
Publicado: (2021)

New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report
por: Bianco, Assunta, et al.
Publicado: (2022)

Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
por: Capone, Fioravante, et al.
Publicado: (2021)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function”
por: DiSano, Krista D., et al.
Publicado: (2021)

CSF chitinase 3-like-1 association with disability of primary progressive MS
por: Pérez-Miralles, Francisco, et al.
Publicado: (2020)

BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression
por: Nociti, Viviana, et al.
Publicado: (2018)

Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression
por: Nociti, Viviana, et al.
Publicado: (2019)

Chitinase 3–like 1 and neurofilament light chain in CSF and CNS atrophy in MS
por: Schneider, Ruth, et al.
Publicado: (2020)

Potential Effect of Cyclophosphamide on Bleb Survival in Five Patients with Multiple Sclerosis Who Underwent Glaucoma Surgery
por: Giudiceandrea, Andrea, et al.
Publicado: (2018)

CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2021)

Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
por: Pilz, Georg, et al.
Publicado: (2020)

Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis
por: Talaat, Foraysa, et al.
Publicado: (2023)

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
por: Masouris, Ilias, et al.
Publicado: (2021)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Chitinases: An update
por: Hamid, Rifat, et al.
Publicado: (2013)

Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer
por: Kzhyshkowska, Julia, et al.
Publicado: (2007)

CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Sato, Tomoo, et al.
Publicado: (2013)

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
por: Kowarik, Markus C, et al.
Publicado: (2012)

Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling
por: Lee, Chun Geun
Publicado: (2009)

The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases
por: Mack, Ines, et al.
Publicado: (2015)

The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study
por: Bientinesi, Riccardo, et al.
Publicado: (2022)

Chitinases as Food Allergens
por: Leoni, Claudia, et al.
Publicado: (2019)

Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12
por: Rigo, Antonella, et al.
Publicado: (2010)

Neutrophils as a Source of Chitinases and Chitinase-Like Proteins in Type 2 Diabetes
por: Żurawska-Płaksej, Ewa, et al.
Publicado: (2015)

Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review
por: Carlomagno, Vincenzo, et al.
Publicado: (2023)

An unusual headache: CSF negative APML relapse in the brain
por: Quinn, Thomas, et al.
Publicado: (2020)

Chitinases and Chitinase-Like Proteins in Obstructive Lung Diseases – Current Concepts and Potential Applications
por: Przysucha, Natalia, et al.
Publicado: (2020)

Unlocking the secrets of chitinase secretion
por: Short, Ben
Publicado: (2014)

G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7gd2stq62bm21scgo57h6nf0si